ESC Premium Access

Clonal hematopoiesis of indeterminate potential (CHIP) in patients with degenerative aortic valve stenosis: incidence, clinical correlates, and prognostic significance following TAVI

Congress Presentation

About the speaker

Associate Professor Silvia Mas-Peiro

Wolfgang Goethe University, Frankfurt (Germany)
1 presentation
0 follower

4 more presentations in this session

Heat Shock Protein 25 Immunotherapy Post-Menopause is Superior to Estradiol in Targeting Atherogenesis, Plasma Cholesterol and PCSK9 Levels

Speaker: Professor E. O'Brien (Calgary, CA)


A novel CT-based radiotranscriptomic signature of perivascular fat improves cardiac risk prediction in the SCOT-HEART and CRISP-CT studies

Speaker: Professor C. Antoniades (Oxford, GB)


The tyrosine kinase inhibitor nilotinib inhibits discoidin domain receptor 2 in human aortic valves, increases aortic valve thickness and induces valvular interstitial cell calcification

Speaker: Professor M. Back (Stockholm, SE)


Dipeptidyl Peptidase-4 Inhibition to Prevent Calcific Aortic Valve Disease: Proof of Concept Study (DIP CAVD_POC)

Speaker: Doctor J. Song (Seoul, KR)


Access the full session

Late Breaking Basic and Translational Science - Atherosclerosis and Aortic Stenosis

Speakers: Associate Professor S. Mas-Peiro, Professor E. O'Brien, Professor C. Antoniades, Professor M. Back, Doctor J. Song

About the event



31 August - 4 September 2019

Sessions Presentations

Related content

Open Access

Welcome and introduction.

29 August 2021

ESC Premium Access

RIPCORD 2 - Panel discussion.

29 August 2021

ESC Premium Access

Clonal hematopoiesis: a novel risk factor and therapeutic target?

29 August 2021

ESC 365 is supported by

logo Novo Nordisk